AMPK Regulates DNA Methylation of PGC-1α and Myogenic Differentiation in Human Mesenchymal Stem Cells
- 1 March 2023
- journal article
- research article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 32 (5-6), 131-139
- https://doi.org/10.1089/scd.2022.0226
Abstract
Adverse intrauterine environments can cause persistent changes in epigenetic profiles of stem cells, increasing susceptibility of the offspring to developing metabolic diseases later in life. Effective approaches to restore the epigenetic landscape and function of stem cells remain to be determined. In this study, we investigated the effects of pharmaceutical activation of AMP-activated protein kinase (AMPK), an essential regulator of energy metabolism, on mitochondrial programming of Wharton's Jelly mesenchymal stem cells (WJ-MSCs) from women with diabetes during pregnancy. Induction of myogenic differentiation of WJ-MSCs was associated with increased proliferator-activated receptor-γ coactivator-1α (PGC-1α) expression and mitochondrial DNA (mtDNA) abundance. Inhibition of DNA methylation by 5 Azacytidine significantly increased PGC-1α expression and mtDNA abundance in WJ-MSCs, which were abolished by AMPK inhibitor Compound C (CC), suggesting an AMPK-dependent role of DNA demethylation in regulating mitochondrial biogenesis in WJ-MSCs. Furthermore, activation of AMPK in diabetic WJ-MSCs by AICAR or metformin decreased the level of PGC-1α promoter methylation and increased PGC-1α expression. Notably, decreased PGC-1α promoter methylation by transient treatment of AMPK activators persisted after myogenic differentiation. This was associated with enhanced myogenic differentiation capacity of human WJ-MSCs and increased mitochondrial function. Taken together, our findings revealed an important role for AMPK activators in epigenetic regulation of mitochondrial biogenesis and myogenesis in WJ-MSCs, which could lead to potential therapeutics for preventing fetal mitochondrial programming and long-term adverse outcome in offspring of women with diabetes during pregnancy.Keywords
This publication has 35 references indexed in Scilit:
- Exercise Prevents Maternal High-Fat Diet–Induced Hypermethylation of the Pgc-1α Gene and Age-Dependent Metabolic Dysfunction in the OffspringDiabetes, 2014
- AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesityMolecular and Cellular Endocrinology, 2013
- Mitochondria as a Potential Regulator of MyogenesisThe Scientific World Journal, 2013
- AMP-activated protein kinase—an energy sensor that regulates all aspects of cell functionGenes & Development, 2011
- Maternal Environment and the Transgenerational Cycle of Obesity and DiabetesDiabetes, 2011
- Deoxyribonucleic Acid Methylation and Gene Expression of PPARGC1A in Human Muscle Is Influenced by High-Fat Overfeeding in a Birth-Weight-Dependent MannerJournal of Clinical Endocrinology & Metabolism, 2010
- Consequences of Fetal Exposure to Maternal Diabetes in OffspringJournal of Clinical Endocrinology & Metabolism, 2006
- Epigenetic Regulation of Stem Cell DifferentiationPediatric Research, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Inhibition of desmin expression blocks myoblast fusion and interferes with the myogenic regulators MyoD and myogeninThe Journal of cell biology, 1994